The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it continues to struggle with recent challenges, an analyst said.

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

As chain pharmacies decline, grocery stores are picking up the slack. Rite Aid’s descent into bankruptcy — and the dash to ...

For CVS Health CVS, the key to building customer trust is to enhance access to life-changing medications and also make them affordable. Beginning July 1, the company’s Pharmacy Benefit Manager ...

The loss of Bartell Drugs is a gut punch to Seattle. But numerous retailers are showing promise, columnist Jon Talton writes.

In the last week of May, soon after it was announced CVS would take over 64 Rite Aid and Bartell stores in the Pacific Northwest, CVS obtained a state business license to soon operate the Snohomish ...

The fate of at least one Seattle-area Bartell Drugs location is clear. A sign spotted this weekend at the register of the Greenwood Bartell at 100 N. 85th St. said the store will be converting to ...

(The Center Square) − Louisiana Attorney General Liz Murrill announced Monday that the state has filed three lawsuits against CVS Health Corp. and its affiliated entities, alleging deceptive and ...

CVS Health (CVS) closed at $67.58 in the latest trading session, marking a +1.15% move from the prior day. This move outpaced the S&P 500's daily gain of 1.11%.

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

Like falling dominoes, another High Desert-based Rite Aid has been marked for permanent closure as the company continues to ...